| Literature DB >> 31034749 |
Laura M Taylor1, Pamela J McMillan2, Brian C Kraemer1,2,3,4, Nicole F Liachko1,3.
Abstract
A number of neurodegenerative diseases are characterized by deposition of abnormally phosphorylated tau or TDP-43 in disease-affected neurons. These diseases include Alzheimer's disease, frontotemporal lobar degeneration, and amyotrophic lateral sclerosis. No disease-modifying therapeutics is available to treat these disorders, and we have a limited understanding of the cellular and molecular factors integral to disease initiation or progression. Phosphorylated tau and TDP-43 are important markers of pathology in dementia disorders and directly contribute to tau- and TDP-43-related neurotoxicity and neurodegeneration. Here, we review the scope of tau and TDP-43 phosphorylation in neurodegenerative disease and discuss recent work demonstrating the kinases TTBK1 and TTBK2 phosphorylate both tau and TDP-43, promoting neurodegeneration. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.Entities:
Keywords: zzm321990ALSzzm321990; zzm321990CBDzzm321990; zzm321990FTLDzzm321990; zzm321990PSPzzm321990; Alzheimer's disease; Pick's disease; TDP-43; TTBK1; TTBK2; phosphorylation; tau; tauopathy
Mesh:
Substances:
Year: 2019 PMID: 31034749 PMCID: PMC6936727 DOI: 10.1111/febs.14866
Source DB: PubMed Journal: FEBS J ISSN: 1742-464X Impact factor: 5.542